At close: 4:10:32 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-38,588.5010
-38,588.5010
-24,421.6860
-21,782.2800
-11,791.3140
Investing Cash Flow
-307.0440
-307.0440
-477.1160
32,680.1820
-15,521.6950
Financing Cash Flow
90,194.0680
90,194.0680
11,440.9640
-182.3620
38,557.8680
End Cash Position
66,874.5790
66,874.5790
15,571.5340
29,110.0230
18,435.1990
Interest Paid Supplemental Data
49.3730
49.3730
27.4340
32.3130
38.8220
Capital Expenditure
-307.0440
-307.0440
-491.1160
-386.9120
-591.0300
Issuance of Capital Stock
92,057.3020
92,057.3020
12,650.0000
--
41,079.1790
Repurchase of Capital Stock
-1,568.7490
-1,568.7490
-976.2480
--
-2,294.6680
Free Cash Flow
-38,895.5450
-38,895.5450
-24,912.8020
-22,169.1920
-12,382.3440
6/30/2021 - 11/17/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PAR.AX Paradigm Biopharmaceuticals Limited
0.4200
-5.62%
TRP.AX Tissue Repair Ltd
0.2550
-1.92%
VBS.AX Vectus Biosystems Limited
0.0770
0.00%
ZLD.AX Zelira Therapeutics Limited
0.6000
0.00%
ZICC.ST Ziccum AB (publ)
0.7460
-10.98%
PTX.AX Prescient Therapeutics Limited
0.0410
-2.38%
CYP.AX Cynata Therapeutics Limited
0.2000
-4.76%
SPL.AX Starpharma Holdings Limited
0.1150
0.00%
TYP.AX TRYPTAMINE FPO [TYP]
0.0420
0.00%
RAC.AX Race Oncology Limited
1.3700
-1.44%